# The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis

> **NCT05931744** · PHASE2,PHASE3 · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 120 (actual)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Prednisone
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05931744
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05931744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05931744, "The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05931744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*